+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more

  • PDF Icon

    Report

  • 236 Pages
  • February 2025
  • Region: United States
  • iData Research
  • ID: 6053659

The U.S. diabetes monitoring, treatment, and drug delivery market was valued at $48 billion in 2024 and is projected to grow at a CAGR of 7.3%, reaching $79 billion by 2031.

This report covers key market segments, including:

  • Blood Glucose Meters, Blood Glucose Test Strips, Lancets
  • Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM)
  • Insulin & GLP-1 Receptor Agonists (e.g., Ozempic®)
  • Insulin Pens, Insulin Syringes, and Insulin Pumps

Key Market Segment Insights

The largest and fastest-growing segment in 2024 was the insulin and GLP-1 receptor agonist market, which accounted for the majority of total market value. The growth of GLP-1 therapies is driven by:

  • Rising prevalence of type 2 diabetes and obesity
  • Increased demand for innovative treatment solutions
  • Advancements in therapies that address both diabetes and obesity
  • Market Data Highlights

The report includes:

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Market Drivers & Limiters
  • Market Forecasts Until 2031 and Historical Data from 2021
  • Competitive Analysis & Market Shares
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • U.S. Diabetes Market Trends
  • Smart Reusable Insulin Pens: The demand for smart insulin pens is increasing due to their ability to track doses, calculate insulin requirements, and provide reminders. These devices enhance diabetes management and offer greater convenience despite higher pricing.
  • Technological Advancements: Continuous improvements in CGM, insulin delivery systems, and digital health solutions are expected to drive the market forward.

Market Share Insights

Top Competitors in the U.S. Diabetes Market (2024):

1 Novo Nordisk

  • Market leader in insulin and second in insulin pens.
  • Top position in ultra-long-acting & ultra-rapid-acting insulin.
  • Only competitor in the rapid-acting insulin market.
  • GLP-1 portfolio includes Ozempic®, Rybelsus®, and Xultophy®.

2 Eli Lilly

  • Second-largest competitor in the insulin market.
  • Leader in premixed insulin, ultra-rapid-acting insulin, and human insulin.
  • GLP-1 portfolio includes Trulicity®, Mounjaro®, and Zepbound®.

3 Dexcom

  • Dominates the continuous glucose monitoring (CGM) market.
  • Strong sales from G6® (FDA approval in 2018) and G7 (FDA approval in 2023).

Market Segmentation Summary

This report suite includes all relevant market data, but individual MedCore reports are available for specific segments.

Blood Glucose Meter Market

  • Segmented Into: Personal & Professional

Blood Glucose Test Strip Market

  • Segmented Into: Personal & Professional

Lancet Market

  • Segmented Into: Personal & Professional

Continuous Glucose Monitoring (CGM) Market

  • Segmented Into: Personal & Professional

Flash Glucose Monitoring (FGM) Market

  • Segmented Into: Readers & Sensors
  • Insulin and GLP-1 Market
  • Insulin Types: Long-Acting, Ultra-Long-Acting, Rapid-Acting, Ultra-Rapid-Acting, Premixed, Human
  • GLP-1 Segments:

Diabetes Care: GLP-1 Injection, GLP-1 Oral

Obesity Care: GLP-1 Injection

Insulin Pen Market

  • Segmented Into: Reusable Pens & Pen Needles

Insulin Syringe Market

  • Segmented Into: Conventional & Safety Syringes

Insulin Pump Market

  • Segmented Into: Durable, Patch, and Simple Pumps
  • Global Research Scope

Report Attributes and Details:

  • Region: United States
  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Coverage:

  • Market Size, Market Shares, Market Forecasts, Growth Rates
  • Units Sold, Average Selling Prices

Qualitative Coverage:

  • COVID-19 Impact
  • Market Trends & Limiters
  • Competitive Analysis & SWOT for Leading Competitors
  • Mergers & Acquisitions
  • Company Profiles & Product Portfolios
  • FDA Recalls & Disruptive Technologies
  • Disease Overviews

Data Sources:

  • Industry Leader Interviews
  • Government & Regulatory Data
  • Hospital & Private Sector Data
  • Import & Export Records
  • Research Internal Database

Table of Contents

  • List of Figures
  • List of Charts
  • Executive Summary
  • U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
  • Competitive Analysis
  • Emerging Markets and Technologies
  • Market Developments
  • Market Trends
  • Market Segmentation
  • Key Report Updates
  • Version History
Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

Disease Overview
2.1 Introduction
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
3.1 Introduction
3.2 Market Overview & Trend Analysis
3.3 Drivers and Limiters
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions

Patient Demographics and Installed Base
4.1 Patient Demographics
4.1.1 Diagnosed Diabetes Patient Population by Type
4.1.2 Diagnosed Type 2 Diabetes Patient Population by Type
4.1.3 Diagnosed Insulin-Dependent Diabetes Patient Population by Type
4.2 Installed Base Analysis and Forecast
4.2.1 Personal Glucose Monitoring Installed Base by Segment
4.2.2 Personal CGM Installed Base by Patient Type
4.2.3 Insulin User Installed Base by Segment
4.2.4 Durable Pump Installed Base by Diabetes Type
4.2.5 Patch Pump Installed Base by Diabetes Type
4.2.6 MDI Installed Base by Segment
4.2.7 MDI Installed Base by Diabetes Type

Blood glucose meter Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
5.3.1 Personal Blood Glucose Meter Market
5.3.2 Professional Blood Glucose Meter Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Blood Glucose test strip Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Total Blood Glucose Test Strip Market
6.3.2 Personal Blood Glucose Test Strip Market
6.3.2.1 Medicare/Medicaid Personal Blood Glucose Test Strip Market
6.3.2.2 Managed Care Personal Blood Glucose Test Strip Market
6.3.2.3 Personal Cash Blood Glucose Test Strip Market
6.3.3 Professional Blood Glucose Test Strip Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Lancet Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Lancet Market
7.3.2 Personal Lancet Market
7.3.3 Professional Lancet Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

Continuous Glucose Monitoring Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Personal Continuous Glucose Monitoring Market
8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
8.3.2 Professional Continuous Glucose Monitoring Market
8.3.2.1 Professional Continuous Glucose Monitoring System Market
8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
8.5.1 Continuous Glucose Monitoring Market Installed Base Share

Flash Glucose Monitoring Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Flash Glucose Monitoring Reader Market
9.3.2 Flash Glucose Monitoring Sensor Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Insulin and GLP-1 Market
10.1 Introduction
10.1.1 Insulin Types
10.1.1.1 Rapid-Acting Insulin Analog
10.1.1.2 Ultra-Rapid-Acting Insulin Analog
10.1.1.3 Regular Human Insulin
10.1.1.4 Intermediate-Acting Human Insulin
10.1.1.5 Long-Acting Insulin Analog
10.1.1.6 Ultra-Long-Acting Insulin Analog
10.1.1.7 Premixed Insulin
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Insulin Market
10.3.1.1 Long-Acting Insulin Market
10.3.1.2 Ultra-Long-Acting Insulin Market
10.3.1.3 Rapid-Acting Insulin Market
10.3.1.4 Ultra-Rapid-Acting Insulin Market
10.3.1.5 Premixed Insulin Market
10.3.1.6 Human Insulin Market
10.3.2 GLP-1 Market
10.3.2.1 GLP-1 Diabetes Care Injection Market
10.3.2.2 GLP-1 Diabetes Care Oral Market
10.3.2.3 GLP-1 Obesity Care Injection Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Insulin pen Market
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Reusable Pen Market
11.3.1.1 Standard Reusable Pen Market
11.3.1.2 Smart Reusable Pen Market
11.3.2 Pen Needle Market
11.3.2.1 Conventional Pen Needle Market
11.3.2.2 Safety Pen Needle Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Insulin Syringe Market
12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
12.3.1 Total Insulin Syringe Market
12.3.2 Conventional Insulin Syringe Market
12.3.3 Safety Insulin Syringe Market
12.4 Drivers and Limiters
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 Competitive Market Share Analysis

Insulin pump Market
13.1 Introduction
13.1.1 Durable Insulin Pumps
13.1.2 Patch Insulin Pumps
13.1.3 Simple Insulin Pumps
13.2 Market Overview
13.3 Market Analysis and Forecast
13.3.1 Durable Insulin Pump Market
13.3.1.1 Durable Pump Market
13.3.1.2 Infusion Set Market
13.3.1.3 Pump Reservoir Market
13.3.2 Patch Insulin Pump Market
13.3.2.1 Patch Pump System Market
13.3.2.2 Insulin Pod Market
13.3.3 Simple Insulin Pump Market
13.4 Drivers and Limiters
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 Competitive Market Share Analysis
13.5.1 Durable Insulin Pump Market
13.5.2 Insulin Pump Market Installed Base Share

Abbreviations
List of Charts
Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2024 - 2031
Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2024 & 2031
Chart 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 - 2031
Chart 3-2: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2024
Chart 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 - 2031
Chart 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 - 2031
Chart 5-2: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
Chart 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 - 2031
Chart 6-2: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
Chart 7-1: Lancet Market by Segment, U.S., 2021 - 2031
Chart 7-2: Leading Competitors, Lancet Market, U.S., 2024
Chart 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031
Chart 8-2: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
Chart 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 - 2031
Chart 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 - 2031
Chart 10-2: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
Chart 11-1: Insulin Pen Market by Segment, U.S., 2021 - 2031
Chart 11-2: Leading Competitors, Insulin Pen Market, U.S., 2024
Chart 12-1: Insulin Syringe Market by Segment, U.S., 2021 - 2031
Chart 12-2: Leading Competitors, Insulin Syringe Market, U.S., 2024
Chart 13-1: Insulin Pump Market by Segment, U.S., 2021 - 2031
Chart 13-2: Leading Competitors, Insulin Pump Market, U.S., 2024

List of Figures
Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (1 of 2)
Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (2 of 2)
Figure 1-3: Companies Researched in this Report, U.S., 2024 (1 of 2)
Figure 1-4: Companies Researched in this Report, U.S., 2024 (2 of 2)
Figure 1-5: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 - 2024 (1 of 2)
Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 - 2024 (2 of 2)
Figure 1-7: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (1 of 2)
Figure 1-8: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (2 of 2)
Figure 1-9: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (1 of 2)
Figure 1-10: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (2 of 2)
Figure 1-11: Patient Demographics and Installed Base Segmentation
Figure 1-12: Key Report Updates
Figure 1-13: Version History
Figure 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
Figure 3-2: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
Figure 3-3: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (1 of 2)
Figure 3-4: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (2 of 2)
Figure 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 - 2031
Figure 4-2: Diagnosed Type 2 Diabetes Patient Population by Type, U.S., 2021 - 2031
Figure 4-3: Diagnosed Insulin-Dependent Diabetes Patient Population by Type, U.S., 2021 - 2031
Figure 4-4: Glucose Monitoring Installed Base by Segment, U.S., 2021 - 2031
Figure 4-5: Personal CGM Installed Base by Patient Type, U.S., 2021 - 2031
Figure 4-6: Insulin User Installed Base by Segment, U.S., 2021 - 2031
Figure 4-7: Durable Pump Installed Base by Diabetes Type, U.S., 2021 - 2031
Figure 4-8: Patch Pump Installed Base by Diabetes Type, U.S., 2021 - 2031
Figure 4-9: MDI Installed Base by Segment, U.S., 2021 - 2031
Figure 4-10: MDI Installed Base by Diabetes Type, U.S., 2021 - 2031
Figure 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 5-2: Personal Blood Glucose Meter Market, U.S., 2021 - 2031
Figure 5-3: Professional Blood Glucose Meter Market, U.S., 2021 - 2031
Figure 5-4: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
Figure 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 6-2: Total Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-3: Personal Blood Glucose Test Strip Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 6-4: Total Personal Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-5: Medicare/Medicaid Personal Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-6: Managed Care Personal Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-7: Personal Cash Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-8: Professional Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
Figure 7-1: Lancet Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 7-2: Total Lancet Market, U.S., 2021 - 2031
Figure 7-3: Personal Lancet Market, U.S., 2021 - 2031
Figure 7-4: Professional Lancet Market, U.S., 2021 - 2031
Figure 7-5: Leading Competitors, Lancet Market, U.S., 2024
Figure 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-2: Personal Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2021 - 2031
Figure 8-4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2021 - 2031
Figure 8-5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2021 - 2031
Figure 8-6: Professional Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-7: Professional Continuous Glucose Monitoring System Market, U.S., 2021 - 2031
Figure 8-8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2021 - 2031
Figure 8-9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2021 - 2031
Figure 8-10: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
Figure 8-11: Leading Competitors, Continuous Glucose Monitoring Market Installed Base Share, U.S., 2024
Figure 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 9-2: Flash Glucose Monitoring Reader Market, U.S., 2021 - 2031
Figure 9-3: Flash Glucose Monitoring Sensor Market, U.S., 2021 - 2031
Figure 9-4: Leading Competitors, Flash Glucose Monitoring Market, U.S., 2024
Figure 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-2: Insulin Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-3: Total Insulin Market, U.S., 2021 - 2031
Figure 10-4: Long-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-5: Ultra-Long-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-6: Rapid-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-7: Ultra-Rapid-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-8: Premixed Insulin Market, U.S., 2021 - 2031
Figure 10-9: Human Insulin Market, U.S., 2021 - 2031
Figure 10-10: GLP-1 Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-11: Total GLP-1 Market, U.S., 2021 - 2031
Figure 10-12: GLP-1 Diabetes Care Injection Market, U.S., 2021 - 2031
Figure 10-13: GLP-1 Diabetes Care Oral Market, U.S., 2021 - 2031
Figure 10-14: GLP-1 Obesity Care Injection Market, U.S., 2021 - 2031
Figure 10-15: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
Figure 10-16: Leading Competitors, Insulin Market, U.S., 2024
Figure 10-17: Leading Competitors, GLP-1 Market, U.S., 2024
Figure 11-1: Insulin Pen Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 11-2: Reusable Pen Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 11-3: Total Reusable Pen Market, U.S., 2021 - 2031
Figure 11-4: Standard Reusable Pen Market, U.S., 2021 - 2031
Figure 11-5: Smart Reusable Pen Market, U.S., 2021 - 2031
Figure 11-6: Pen Needle Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 11-7: Total Pen Needle Market, U.S., 2021 - 2031
Figure 11-8: Conventional Pen Needle Market, U.S., 2021 - 2031
Figure 11-9: Safety Pen Needle Market, U.S., 2021 - 2031
Figure 11-10: Leading Competitors, Insulin Pen Market, U.S., 2024
Figure 12-1: Insulin Syringe Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 12-2: Total Insulin Syringe Market, U.S., 2021 - 2031
Figure 12-3: Total Conventional Insulin Syringe Market, U.S., 2021 - 2031
Figure 12-4: Safety Insulin Syringe Market, U.S., 2021 - 2031
Figure 12-5: Leading Competitors, Insulin Syringe Market, U.S., 2024
Figure 13-1: Insulin Pump Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 13-2: Durable Insulin Pump Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 13-3: Durable Pump Market, U.S., 2021 - 2031
Figure 13-4: Infusion Set Market, U.S., 2021 - 2031
Figure 13-5: Pump Reservoir Market, U.S., 2021 - 2031
Figure 13-6: Patch Insulin Pump Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 13-7: Patch Pump System Market, U.S., 2021 - 2031
Figure 13-8: Insulin Pod Market, U.S., 2021 - 2031
Figure 13-9: Simple Insulin Pump Market, U.S., 2021 - 2031
Figure 13-10: Leading Competitors, Insulin Pump Market, U.S., 2024
Figure 13-11: Leading Competitors, Durable Insulin Pump Market, U.S., 2024
Figure 13-12: Leading Competitors, Insulin Pump Market Installed Base Share, U.S., 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott
  • Home Aide Diagnostics
  • ACON Laboratories
  • iHealth Labs
  • AgaMatrix
  • Infopia
  • Allison Medical
  • Insulet
  • ApexBio
  • Intuity Medical
  • Arcadia Group
  • i-SENS
  • ARKRAY
  • LifeScan
  • Ascensia
  • Livongo Health
  • AstraZeneca
  • McKesson
  • B. Braun
  • Medlin
  • BD
  • Medtronic
  • Bionime
  • Nova Biomedical
  • Biosense Medical Devices
  • Novo Nordisk
  • Boehringer Ingelheim
  • Oak Tree Health
  • Companion Medical
  • Omnis Health
  • CanAm
  • One Drop
  • CVS
  • Owen Mumford
  • DarioHealth
  • Perrigo
  • Eli Lilly
  • Pharma Supply
  • Excel International
  • Philosys
  • Fifty 50 Medical
  • Platinum Equity
  • ForaCare
  • Playtex
  • Genesis Health Technologies
  • Prodigy
  • Gluco Perfect
  • Retractable Technologies
  • Hikma Pharmaceuticals
  • Roche
  • Sanofi
  • Terumo
  • SD Biosensor
  • Trivia Health
  • Senseonics
  • U.S. Diagnostics
  • Simple Diagnostics
  • UltiMed
  • Smart Meter
  • Unilife Medical Solutions
  • Smiths Medical
  • Valeritas
  • Specialty Medical Supplies
  • Vertex Diagnostics
  • STAT Medical Devices
  • Viatris
  • Tandem
  • Walmart
  • Teva Pharmaceuticals
  • Ypsomed
  • Telcare